MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$307,397
EPS
-$0.02
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative
212,254
262,149
305,871
270,153
Research and development
66,406
117,064
34,942
20,454
Stock-based compensation
24,782
210,016
281,246
277,226
Total operating expenses
303,442
589,229
622,059
567,833
Interest expense, net
3,955
1,260
1,068
958
Net loss
-307,397
-590,489
-623,127
-568,791
Basic EPS
-0.02
-0.03
-0.033
-0.03
Diluted EPS
-0.02
-0.03
-0.033
-0.03
Basic Average Shares
18,808,072
18,754,739
18,821,710
18,579,776
Diluted Average Shares
18,808,072
18,754,739
18,821,710
18,579,776
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$307,397
(52.67%↑ Y/Y)
Total operating
expenses
$303,442
(-53.20%↓ Y/Y)
Interest expense, net
$3,955
(269.63%↑ Y/Y)
General and
administrative
$212,254
(-44.69%↓ Y/Y)
Research and development
$66,406
(360.19%↑ Y/Y)
Stock-based compensation
$24,782
(-90.09%↓ Y/Y)
Buy us a coffee
RetinalGenix Technologies Inc. (RTGN)
RetinalGenix Technologies Inc. (RTGN)